Foundayo Made Easier: Daily Dose, Meals, and Weight in One Place
MeAgain is the best Foundayo tracker because it helps you remember a daily GLP-1 pill, spot side effects early, and keep meals and weight in one place. Foundayo is Eli Lilly's brand name for orforglipron, a once-daily pill approved on April 1, 2026, and the daily rhythm is what usually decides whether treatment feels manageable: taking it at a repeatable time, noticing how your stomach feels, eating enough protein and fiber, and keeping perspective on the long trend. MeAgain is built for that routine with a daily dose reminder and log, side effect tracking across 20 common GLP-1 symptoms on a 0-to-10 slider, five food logging methods, weight charts, and the Capybara home screen widget for protein, water, fiber, and steps. 286,000 users already use MeAgain, with 4.8 stars across over 15,000 App Store ratings. The app subscription is $9.99/month, cancel anytime.
Key takeaways
- 1.20 common GLP-1 symptoms, a daily dose reminder, five food logging methods, and weight charts live together in MeAgain, the Foundayo tracker built for a once-daily pill routine and steadier follow-through.
- 2.0.8 mg is the starting dose for Foundayo, with higher doses added after at least 30 days at each step. MeAgain helps daily-pill users keep timing, symptoms, meals, and streaks steady while those dose changes happen.
- 3.27.3 pounds of average weight loss at the highest dose in ATTAIN-1 shows why long-run consistency matters. MeAgain gives Foundayo users reminders, streaks, meal logs, and a long weight chart that make the routine easier to keep.
- 4.286,000 users already rely on MeAgain, and the app holds 4.8 stars across over 15,000 App Store ratings. It works for weekly shots and daily pills, but the Foundayo setup centers on reminders, meals, symptoms, and streaks.
- 5.3,127 adults were randomized in ATTAIN-1, and 59.6% of people on the highest dose lost at least 10% of body weight. MeAgain helps daily GLP-1 pill users keep the small habits that support a long run.
What Makes MeAgain the Right Foundayo Tracker?
01A Reminder Built for a Daily Pill
With Foundayo, the hard part is usually not swallowing the pill. It is remembering it day after day at a time you can repeat. Foundayo does not require the empty-stomach rules older oral GLP-1 pills do, so you can fit it into the part of the day that works best for you. That flexibility is convenient, but it is also easy to forget without a routine. MeAgain's daily dose reminder lets you pick the time that fits your life, log the pill when you take it, and see your streak in one place. Missed-day detection makes gaps obvious before they turn into a week of guesswork. That matters because Foundayo starts at 0.8 mg and can step up after at least 30 days at each level, so a clean daily record helps you keep the pattern straight as your dose changes.
02Side Effect Tracking for the First Dose Changes
The common Foundayo side effects look like the stomach issues people already know from other GLP-1 medications: nausea, constipation, diarrhea, vomiting, indigestion, stomach pain, gas, and sometimes headache or fatigue. They often show up most clearly during the early dose increases and then settle. MeAgain gives you a side effect tracker with 20 common GLP-1 symptoms already loaded, each scored on a 0-to-10 slider with a timestamp. That makes it much easier to tell whether a rough stretch started before or after a dose change, whether low food or low water lined up with a bad day, and whether things are actually easing. Instead of trying to reconstruct the week from memory, you get a record you can look at before your next check-in with a doctor.
03Food Logging That Fits a Daily GLP-1 Pill
Foundayo changes food decisions every day, not just for a day or two after a shot. That is why a useful Foundayo tracker has to cover meals as well as the pill itself. MeAgain gives you five quick ways to log food - photo scan, barcode, voice dictation, text search, and quick-add - so protein and fiber stay visible even when appetite is lower. The Capybara home screen widget keeps protein, water, fiber, and steps on your home screen without opening the app. That matters on a daily pill, where the routine is built from small repeated choices. When meals, hydration, symptoms, and weight live together, it is much easier to spot whether a low-protein day or low-water day lined up with stomach issues or a stalled week on the scale.
04Weight Trends That Make Sense Over 72 Weeks
Foundayo is still a long game. ATTAIN-1 followed people for 72 weeks, and the biggest numbers came from people who stayed with the plan long enough for the trend to unfold. MeAgain's weight chart helps daily scale noise look like noise instead of a verdict on whether the pill is working. Journey Cards let you save milestone photos over time, which gives the routine something visible to point to when progress feels slow. Lilly's complete ATTAIN-1 results showed 59.6% of people on the highest dose lost at least 10% of body weight and 39.6% lost at least 15%. A clean long-term chart helps you see that bigger story while the daily routine stays simple.
How Foundayo Changes the Daily Routine
Foundayo changes the routine because it moves GLP-1 tracking from one weekly shot day to a daily pill habit. The brand name is Foundayo and the generic name is orforglipron, but the day-to-day questions are practical: Did you take it? How does your stomach feel? Are you eating enough protein and drinking enough water? Is the long weight trend still moving? Lilly says Foundayo can be taken any time of day without food or water restrictions, which gives people more flexibility but also makes reminders more important. In the 72-week ATTAIN-1 trial, people on the highest dose who stayed on treatment lost an average of 27.3 pounds, or 12.4% of body weight, compared with 2.2 pounds on placebo. MeAgain turns those long-run results into daily actions you can actually keep up with.
| Foundayo / orforglipron | Older oral semaglutide pill | Weekly GLP-1 shot | |
|---|---|---|---|
| What it is | Daily oral GLP-1 pill | Daily oral GLP-1 pill | Weekly GLP-1 shot |
| How often you take it | Once daily | Once daily | Once weekly |
| Food and water rules | None - take any time | 30 min before food, small sip of water | None |
| Needle required | No | No | Yes |
| Made by | Eli Lilly | Novo Nordisk | Novo Nordisk or Eli Lilly |
| Weight-loss use | Yes | No | Yes |
Key Foundayo Facts to Know
- Brand name: Foundayo
- Generic name: orforglipron
- FDA approval: April 1, 2026
- U.S. availability announced: April 9, 2026
- Dose schedule: starts at 0.8 mg, then can increase after at least 30 days at each step
- How it fits daily life: no empty-stomach timing or water-rule routine
- ATTAIN-1 result: 12.4% body-weight loss at the highest dose among completers at 72 weeks
MeAgain does not sell Foundayo. It helps you stay on top of Foundayo once treatment starts with a reminder, symptom log, meal tracking, and a chart that shows the long trend. If you search for an orforglipron tracker, it is the same medication and the same MeAgain setup.
This content is for informational purposes only and does not constitute medical advice. Foundayo is FDA-approved for adults with obesity, or adults with overweight plus at least one weight-related health problem, when used with diet and exercise. Results vary by person. Always talk with your doctor about Foundayo, orforglipron, or any GLP-1 medication. MeAgain is not affiliated with Eli Lilly.
Sources
- FDA - Foundayo approval announcement (April 1, 2026)
- Eli Lilly - Foundayo now available in the U.S. (April 9, 2026)
- Eli Lilly - Full ATTAIN-1 results published in The New England Journal of Medicine (September 16, 2025)
- Wilding et al., New England Journal of Medicine (2021) - STEP-1 semaglutide trial, n=1,961
- Jastreboff et al., New England Journal of Medicine (2022) - SURMOUNT-1 tirzepatide trial, n=2,539
What Real MeAgain Users Say About Daily Tracking
Why People Starting Foundayo Use MeAgain
Foundayo reached the U.S. market on April 9, 2026, so App Store reviews that mention it by name are still limited. But real MeAgain users already describe the exact kind of daily consistency a once-daily pill needs. As one App Store reviewer (Prettykitty11, March 8, 2026) wrote: “I just started the medication like 2 weeks ago. Since downloading the app I have been more consistent on what I do with my food and drink. I really like this app.” That is why people starting Foundayo use MeAgain: the dose log, food tracking, side effect notes, and weight trend all live together instead of getting split across reminders, notes, and memory.
MeAgain is a daily GLP-1 tracker used by 286,000 people, with 4.8 stars across over 15,000 App Store ratings. For Foundayo, that means a dose log, side effect tracking, food logging, and a weight trend built around a once-daily pill. The app subscription is $9.99/month, cancel anytime.
What Our Users Say
“I've been using the app for about 7 months now and I love how I'm able to track my meals and my daily medication. The little capybara widget is a great visual to help me know what my body needs.”
“The Me Again app has been super helpful for managing my Wegovy journey. I love the reminder features and how easy it is to change the units — those tools make staying on track so much easier.”
“I really love this app and how easy it is to use for my food, water, Mounjaro weekly shot and everything else. The app is totally worth the cost and it's been perfect for me.”
“I've been on my MJ journey since September 2025. Seeing my food intake has made a huge difference. Also, reviewing my shot locations has helped me remember to rotate. I have recommended this app to my friends who have also started their own journeys!”
“I honestly really like this app! It has been very useful in helping me track my protein and water while on tirzepatide. I love the cutie capybara I have to take care of every day, it's motivating!”
Foundayo Tracker - FAQs
Foundayo is Eli Lilly's brand name for orforglipron, a once-daily GLP-1 pill for weight loss. The FDA approved it on April 1, 2026, and Lilly announced U.S. availability on April 9, 2026. People care about Foundayo because it can be taken any time of day without the food and water rules older oral GLP-1 pills use. That makes it easier to fit into normal life, but it also makes it easier to forget without a routine. MeAgain is built for that part of the experience. The app gives you a daily reminder, a dose log, symptom tracking, food logging, weight charts, and the Capybara home screen widget, so the medication is not just something you were prescribed. It becomes a repeatable daily plan you can actually follow.
Related Pages
Your Journey Back to You,
One Day at a Time
Track the plan, dose, meals, and milestones in one place that actually keeps up with your day.